Global $1 Billion Blood Gas and Electrolyte Analyzers Market Trajectory & Analytics to 2027 - ResearchAndMarkets.com

The "Blood Gas and Electrolyte Analyzers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Monitoring Needs in Intensive Care Units Dramatically Spikes as COVID-19 Infections & Hospitalization Rates Increase. Blood Gas and Electrolyte Analyzers Demand Spikes by 10.1%

The global market for Blood Gas and Electrolyte Analyzers is expected to spike by 10.1% in the year 2020 and continue to grow to reach US$1 billion by the year 2027, trailing a post COVID-19 CAGR of 5.1% over the analysis period 2020 through 2027.

The increase in COVID-19 hospitalizations is more than counterbalancing the decline in non-COVID-19 ICU admissions due to surgery cancellations and postponement. Hospitalization rates remain high in the age group of 60 to 79 years. The overwhelming caseload of COVID-19 patients globally has burdened the healthcare system and created a pressing demand for diagnostic solutions and medical interventions. For COVID-19 patients that display signs of respiratory distress, or who are admitted in ICU units and are on ventilation support, blood gas testing is considered crucial.

The assessment of damage caused due to COVID-19 in patients requires several diagnostic tests and medical interventions. While reverse transcription-polymerase chain reaction (RT-PCR) tests remain gold standard to diagnose the infection, critical care tests including blood gas and electrolyte analyzers are gaining attention among the medical fraternity for effective treatment decisions. Arterial blood gas analyzers offer measurement related to acid-base status and blood oxygenation along with gas exchange efficiency of the lungs. The device gains relevance in helping medical professionals effectively manage COVID-19 patients while making relevant treatment decisions.

Arterial blood gas is a common test used for measuring blood acid and oxygenation levels along with diagnosing respiratory or renal conditions. Respiratory systems of patients are critically damaged by COVID-19 infection are hence they are unable to move oxygen inside the body and remove carbon dioxide. Also acid-base imbalance is common in patients suffering from severe viral infections, such as COVID-19.

Hence accurate measurement of blood gas results is important to manage the progression of the disease in patients to assess their critical condition. The requirement to monitor these patients is driving volume demand for blood gas and electrolyte analyzers in hospitals. Blood gas and electrolyte analyzers measure various parameters from blood samples, such as pH, pCO2 and pO2, electrolytes, and metabolites. The pH value of blood and serum indicates the balance between the blood, renal, and lung systems, while the pCO2 value is used to assess the amount of carbon dioxide eliminated from the body, and the pO2 value of arterial blood indicates oxygen absorbance in the lungs.

Depending on patient care scenario, physicians are relying on sophisticated critical care testing devices such as cartridge combinations of electrolytes and gases. The increasing use of these systems for point-of-care testing in laboratories and acute care venues such as COVID-19 emergency rooms, intensive care units and ambulances is boosting demand for blood gas and electrolyte analyzers.

To leverage the opportunities for growth, several companies are launching advanced devices. Radiometer, a major provider of blood gas testing solutions, is offering ABL800 Flex blood gas analyzers for automated sampling and high throughput. Instrumentation Laboratory is serving healthcare needs with its advanced Gem Premier 5000 blood gas testing platform that offers automated quality with each sample. The device quickly identifies and automatically rectifies errors.

While Roche Diagnostics and Nova Biomedical are offering cobas b 123 point-of-care and StatProfile pHOx Ultra systems, respectively, for enhanced throughput. On the other hand, Abbott is riding high on the popularity of its handheld i-Stat 1 blood analyzer solution for critical care that allows menu expansion for including various chemistries, electrolyte, blood gases, hematology, coagulation and cardiac markers. Epoc, a handheld wireless device from Siemens Healthineers, supports exhaustive blood analysis testing at bedside. These sophisticated solutions from vendors are anticipated to improve patient care by enabling physicians to make informed and better treatment decisions.

Siemens Healthineers has secured US FDA approval for its advanced RapidPoint 500e blood gas analyzer for critical care testing. The device is intended measure electrolyte, blood gas, Co-oximetry, metabolite and neonatal bilirubin levels to aid diagnosis and monitoring of critically-ill patients in emergency rooms, intensive care units and operating rooms. Monitoring of respiratory conditions in point-of-care settings involves the use of blood gas testing devices capable of offering accurate and fast results while improving workflow efficiency. The analyzer is built on Integri-sense technology that allows automated functional checks for accurate results at point-of-care settings.

In addition, RAPIDPoint 500e blood gas analyzer seamlessly integrates into hospital networks using the company's Point of Care Ecosystem for remote, convenient management of devices and operators at multiple sites. The new device holds a critical role in response efforts towards COVID-19 that depend heavily on blood gas testing for patient monitoring and management.

Competitors identified in this market include, among others:

• Abbott Point of Care, Inc.
• Convergent Technologies GmbH & Co. KG
• DALKO Diagnostics
• EDAN Instruments, Inc.
• Erba Mannheim
• F. Hoffmann-La Roche AG
• Instrumentation Laboratory, a Werfen Company
• Medica Corporation
• OPTI Medical Systems, Inc.
• Radiometer Medical ApS
• Siemens AG
• Tecom Analytical Systems

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Impact of Covid-19 and a Looming Global Recession
• Life-Saving Interventions for COVID-19 Patients Drive Importance of Blood Gas & Electrolyte Analyzers
• Industry Witnesses Inflow of Sophisticated Solutions
• Blood Gas and Electrolyte Analyzers: An Introduction
• Types of Analyzers
• Fundamentals of Blood Gases and Blood Gas Testing
• Blood Gas Parameters and their Significance
• Outlook
• Point-of-Care Analyzers Gain Significance
• Hurdles to Overcome
• Competition
• Recent Industry Activity
• World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Decentralized Testing Gains Traction
• Technology Advancements: Cornerstone for Market Growth
• Select New Devices
• Advanced Sensors Give Way to Modern Devices
• Blood Gas Testing Becomes Commonplace in Critical Care
• Benchtop Makers Cash in on the Lucrative POC Market
• Advanced Solutions for Point-of-Care & Critical Care Settings
• Integration with LIS and EMR Widens Functionality
• Miniaturised Blood Gas Analysers Gain Traction
• Increasing Prevalence of Chronic Disorders and Patient admissions Fuels Market Growth
• Assessment of Various Conditions Based on Blood Gas Testing
• Alarming Levels of Diabetes Incidence Worldwide Drives Demand
• Rise in CVD Incidence Spurs Demand
• Rising Cancer Incidence and Ensuing Rise in Critical Care Admissions Create Need for Blood Gas and Electrolyte Analyzers
• Rise in Prevalence of COPD Augments Demand
• Rising Aging Population: Principal Driver for the BGA Market
• Healthcare Cost-Cutting Trend Promotes Innovations

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 53

For more information about this report visit https://www.researchandmarkets.com/r/tws3jo

View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005392/en/